Sponsored
- Female
- 17/11/1997
- Followed by 0 people
Recent Updates
- Global Aptamers Market by Industry Trends and Global Forecasts, 2022-2035THE RISING REALM AMONGST STAKEHOLDERS IN PURSUIT OF ALTERNATIVE THERAPIES TO ANTIBODIES THERAPIES Aptamers have gained a lot of momentum in the past decade. It is worth highlighting that in 2005, Macugen became the first and the only USFDA approved aptamer drug for treating age-related macular degeneration (AMD). It has been reported that more than 15 million people in the US suffer from AMD...0 Comments 0 SharesPlease log in to like, share and comment!
-
More Stories
Sponsored